TAG:
commercial laboratories
Shareholders Hugely Oversubscribe LabCorp’s $500 Million Offering
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
COMMERCIAL LABORATORIES may be regaining favor on Wall Street. Laboratory Corporation of America’s $500 million convertible stock offering not only sold out, but was over-subscribed by a huge amount. In addition to the 10 million convertible shares offered, subsc…
National Labs Cut Costs Using Radical Strategies
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: All three national laboratories are dumping unprofitable accounts and unprofitable lines of testing. It ends the era when commercial labs “gave away” testing to any client willing to open an account. The three national laboratories are enacting stiffer requirements for ne…
National Lab Strategies Will Impact Competitors
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Not since the era of commercial lab consolidation ended has such a significant trend emerged. As the three national labs eliminate service to unprofitable accounts, profound changes will occur to the market for laboratory and pathology services. How quickly this leads to impr…
Lab Information Systems Meeting Highlights Innovation, Ideas
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Managed care’s pressure to create clinically integrated healthcare delivery systems changes the way laboratories report, use and warehouse clinical data. Dr. Bruce Friedman’s annual laboratory information systems conference in Ann Arbor provided graphic evidence that tech…
Roche Holdings, Ltd. Acquires Boehringer Mannheim In Merger
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Roche will pay $11 billion to buy Corange Ltd., parent company of Boehringer Mannheim, the world’s number two diagnostics company. Wall Street expects this deal to quicken the pace of consolidation in the healthcare industry. The surprise move will impact clinical laborator…
“June 2, 1997 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
With commercial laboratories pressing hospital laboratories for joint ventures, a unique selling proposition helps. MDS-AutoLab, Inc. of Canada has a different twist. They will not sell you their automated laboratory equipment. Instead, they offer it on a profit-sharing type of arran…
Ex-NHL Executives Buy American Medical Labs
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: American Medical Laboratories’ sale to new owners is a major event. Not only does the new management team have a reputation for top performance in selling clinical laboratory services, but they also arrive with an ample war chest. When the revamped AML hits the competitive …
Regional Lab Systems Beginning To Emerge
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: Regionalization of laboratory services is about to become a dominant industry trend. Four groups of players will drive this process and each needs to recruit hospital laboratories to participate in their regional model. This is the first generation of attempts to create finan…
New Hybrid Lab Systems Provide Peek At Future
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: As the first generation of regional laboratory systems begin operation, the marketplace is about to separate winners from losers. Stakes are high for hospital laboratory administrators. If they choose to affiliate with the wrong model, the consequences can cause extended disr…
Where’s The Write-down ? LabCorp Faces Key Decision
By Robert Michel | From the Volume IV No. 6 – April 21, 1997 Issue
CEO SUMMARY: Commercial laboratories are recognizing declines in the market value of their assets. LabCorp has yet to do the same. Taken cumulatively, these write-downs demonstrate the sizable revenue erosion that large commercial laboratories experienced during the past three years. Soon…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized